Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
165.40
0.00 (0.00%)
Jun 18, 2025, 4:00 PM - Market closed
Cardinal Health Revenue
Cardinal Health had revenue of $54.88B in the quarter ending March 31, 2025, with 0.02% growth. This brings the company's revenue in the last twelve months to $222.29B, up 0.86% year-over-year. In the fiscal year ending June 30, 2024, Cardinal Health had annual revenue of $226.83B with 10.66% growth.
Revenue (ttm)
$222.29B
Revenue Growth
+0.86%
P/S Ratio
0.18
Revenue / Employee
$4,545,726
Employees
48,900
Market Cap
39.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 226.83B | 21.85B | 10.66% |
Jun 30, 2023 | 204.98B | 23.65B | 13.04% |
Jun 30, 2022 | 181.33B | 18.86B | 11.61% |
Jun 30, 2021 | 162.47B | 9.55B | 6.24% |
Jun 30, 2020 | 152.92B | 7.39B | 5.08% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CAH News
- 8 days ago - Cardinal Health raises annual profit target - Reuters
- 8 days ago - Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day - PRNewsWire
- 8 days ago - Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth - Benzinga
- 16 days ago - Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system - PRNewsWire
- 23 days ago - Best Dividend Aristocrats For June 2025 - Seeking Alpha
- 6 weeks ago - 63 Top Dividend Growth Stocks For May 2025 - Seeking Alpha
- 6 weeks ago - Cardinal Health releases new report on the cell and gene therapy industry - PRNewsWire
- 6 weeks ago - Cardinal Health Board of Directors Approves Quarterly Dividend - PRNewsWire